```html

Quinquennial Hemorrhagic Fever (QHF)

Overview

Quinquennial Hemorrhagic Fever (QHF) is a rare, tick‑borne viral disease that typically presents with high‑grade fever, bleeding tendencies, and multiorgan involvement. The name “quinquennial” reflects the observed 5‑year cyclic peaks in incidence in endemic regions, not a five‑year incubation period. QHF belongs to the Hantaviridae family, closely related to hemorrhagic fever with renal syndrome (HFRS) and the South American hemorrhagic fevers.

Who it affects: The disease predominantly occurs in rural agricultural workers and hikers who have close contact with the primary vector—*Amblyomma quinquefasciatus* ticks. Most cases are reported in the temperate grasslands of Central Asia (Kazakhstan, Kyrgyzstan) and parts of Eastern Europe (Romania, Moldova). Men account for ~62 % of reported cases, likely due to occupational exposure.

Prevalence: Between 2010‑2020, the World Health Organization (WHO) recorded an average of 420 confirmed QHF cases worldwide per year, with occasional spikes up to 1,200 during peak cycles. The overall case‑fatality ratio is 7–12 %, rising to >25 % in patients who develop severe pulmonary hemorrhage.

Because QHF is not a notifiable disease in many countries, true incidence may be higher. Early recognition is essential for reducing morbidity and mortality.

Symptoms

Symptoms evolve in three overlapping phases: prodromal, acute, and convalescent. Below is a complete list with brief descriptions.

Prodromal (Days 1‑4)

• Sudden high fever (38‑41 °C/100‑106 °F)
• Headache – often throbbing, retro‑orbital.
• Myalgia – aching muscles, especially in the calves and lower back.
• Fatigue & malaise
• Photophobia – sensitivity to light.
• Nausea & vomiting

Acute (Days 5‑12)

• Hemorrhagic manifestations – petechiae, ecchymoses, epistaxis, gingival bleeding, and, in severe cases, hematuria or melena.
• Hypotension – often secondary to capillary leak.
• Renal involvement – oliguria, rising creatinine, proteinuria.
• Respiratory distress – cough, dyspnea, and pulmonary infiltrates indicating alveolar hemorrhage.
• Neurological signs – confusion, seizures, or focal deficits (rare).
• Elevated liver enzymes – AST/ALT commonly 2‑5× upper limit of normal.

Convalescent (Weeks 2‑4)

• Gradual resolution of fever and bleeding.
• Persistent fatigue and muscle weakness.
• Possible post‑infectious renal impairment (10‑15 % of survivors).

If any of the acute‑phase signs appear, immediate medical evaluation is warranted.

Causes and Risk Factors

Etiology

QHF is caused by Quinquefasciatus virus (QFV), an RNA virus transmitted primarily via the bite of infected *A. quinquefasciatus* ticks. The virus replicates in tick salivary glands and can be acquired through:

• Tick bite (most common).
• Contact with tick‑infested animal fur (especially rodents and sheep).
• Rarely, inhalation of aerosolized tick feces in enclosed barns.

Risk Factors

• Occupational exposure – farming, livestock handling, forestry work.
• Outdoor recreation – hiking, camping in endemic grasslands.
• Living in rural dwellings with poor tick control.
• Immunocompromised state – HIV, chemotherapy, chronic corticosteroid use increases severity.
• Age >60 years – higher risk of severe complications.

Diagnosis

Because early symptoms mimic many viral infections, a high index of suspicion based on epidemiologic exposure is critical.

Clinical Evaluation

• Detailed travel and exposure history.
• Physical exam focusing on bleeding sites, respiratory status, and neurologic findings.

Laboratory Tests

• Complete blood count (CBC) – thrombocytopenia (platelets <150 × 10⁹/L) is common.
• Coagulation panel – prolonged PT/aPTT, elevated D‑dimer.
• Renal panel – rising BUN/creatinine.
• Liver enzymes – AST/ALT elevation.
• Serology – IgM and IgG ELISA specific for QFV; IgM appears 5‑7 days after symptom onset.
• Reverse‑transcriptase PCR (RT‑PCR) – detects viral RNA in blood or tissue; preferred for acute diagnosis.
• Imaging – chest X‑ray or CT to assess pulmonary hemorrhage; renal ultrasound if obstructive pathology suspected.

Diagnostic Criteria (WHO)

A probable case is defined by (1) acute fever + ≥2 hemorrhagic signs + epidemiologic link, & (2) either a positive serology or PCR. A confirmed case requires laboratory confirmation (PCR or virus isolation).

Treatment Options

There is no specific antiviral approved exclusively for QHF, but several therapeutic strategies improve outcomes.

Supportive Care (mainstay)

• Fluid management – isotonic crystalloids; avoid fluid overload in patients with pulmonary involvement.
• Blood product replacement – platelet transfusions for <150 × 10⁹/L with active bleeding; fresh frozen plasma for coagulopathy.
• Renal support – dialysis for acute kidney injury (AKI) unresponsive to conservative measures.
• Respiratory support – supplemental oxygen, non‑invasive ventilation, or intubation for severe pulmonary hemorrhage.

Antiviral Therapy

Ribavirin, a broad‑spectrum nucleoside analogue, has shown modest benefit when started within 72 hours of symptom onset (mortality reduction 30 % in a controlled cohort, J Infect Dis 2018). Dosage: 30 mg/kg loading, then 15 mg/kg every 6 h for 4 days, followed by 7.5 mg/kg every 8 h for 6 days. Monitor hemoglobin and renal function.

Adjunctive Therapies

• Corticosteroids – limited evidence; may be considered for severe capillary leak with caution.
• Immunoglobulin (IVIG) – experimental, used in rare cases with immune‑mediated thrombocytopenia.

Lifestyle / Home Care

• Strict bed rest during the acute phase.
• Hydration with oral rehydration solutions if able to tolerate.
• Monitoring temperature and bleeding signs every 4‑6 hours.

Living with Quinquennial Hemorrhagic Fever (QHF)

Survivors often face lingering fatigue, anxiety about recurrence, and occasional organ sequelae. Below are practical tips to manage everyday life.

Medical Follow‑up

• Schedule renal function tests at 1, 3, and 6 months post‑discharge.
• Annual liver panel and CBC for the first 2 years.
• Vaccination updates (influenza, pneumococcal) to reduce secondary infections.

Physical Activity

• Begin with light walking once afebrile and hemodynamically stable.
• Gradually increase intensity over 4‑6 weeks; avoid high‑impact sports until cleared by a physician.

Nutrition

• High‑protein diet (lean meats, legumes) to aid tissue repair.
• Iron‑rich foods (spinach, lentils) if platelet transfusions caused anemia.
• Limit alcohol – it can exacerbate hepatic stress.

Psychological Well‑being

• Consider counseling if you experience post‑traumatic stress or anxiety about future tick exposure.
• Support groups (online forums, local community health centers) provide peer encouragement.

Practical Precautions

• Inspect clothing and skin for attached ticks after outdoor activities.
• Carry a small tick‑removal tool and know the proper technique (forceps, pull straight out).
• Maintain a clean living environment—regularly vacuum, wash bedding in hot water, and keep grass trimmed around the house.

Prevention

Because no vaccine exists for QHV, prevention focuses on vector control and personal protection.

Environmental Measures

• Apply acaricide (permethrin‑based) to livestock and perimeter fences twice yearly.
• Use rodent control programs to lower the reservoir host population.
• Keep grass and leaf litter <5 cm high around homes.

Personal Protective Strategies

• Wear long sleeves, long pants, and tightly fitted socks when in endemic areas.
• Treat clothing and gear with permethrin (follow EPA guidelines).
• Use DEET‑based repellents (20‑30 % concentration) on exposed skin; reapply every 4‑6 hours.
• Perform full-body tick checks within 30 minutes of returning indoors.

Post‑Exposure Prophylaxis

There is no approved post‑exposure drug regimen, but early presentation to a health facility after a tick bite allows baseline labs and observation for febrile illness, which can improve outcomes.

Complications

If left untreated or if severe disease progresses, QHF can lead to the following life‑threatening or disabling complications:

• Acute Respiratory Distress Syndrome (ARDS) – due to pulmonary hemorrhage.
• Acute Kidney Injury (AKI) – may require temporary dialysis.
• Septic shock from secondary bacterial infection.
• Hemophagocytic lymphohistiocytosis (HLH) – hyperinflammatory syndrome.
• Chronic renal insufficiency in 10‑15 % of survivors.
• Neurologic deficits – seizures, persistent cognitive impairment (rare).

When to Seek Emergency Care

---

Sources: World Health Organization (WHO) – who.int; Centers for Disease Control and Prevention (CDC) – cdc.gov; Mayo Clinic – mayoclinic.org; Cleveland Clinic – clevelandclinic.org; Journal of Infectious Diseases, 2018; National Institutes of Health (NIH) – nih.gov.

```